| 1 | (S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo | - | - | - | - | [1] 284 284 |
| 2 | (S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide | [3] Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | [1] D00731
D00731
| - | - | [1] 284 284 |
| 3 | (S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m | - | - | - | - | [1] 284 284 |
| 4 | (S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide | [3] Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | [1] D00731
D00731
| - | - | [1] 284 284 |
| 5 | Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
| 6 | Alefacept | [1] Alefacept Alefacept | [1] D02800
D02800
| [1] CD58 CD58 💬 | [2] Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection 💬 | [6] 37 37, 60, 65, 164, 284, 285 |
| 7 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
| 8 | Allogeneic Bone Marrow Transplantation | - | - | - | - | [9] 60 60, 62, 65, 96, 164, 283, 284, 285, 286 |
| 9 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | [8] 28 28, 51, 60, 62, 65, 164, 284, 285 |
| 10 | Alpha beta depletion | - | - | - | - | [2] 60 60, 284 |
| 11 | Anti-Thymocyte Globulin | - | - | - | - | [18] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 |
| 12 | Antithymocyte Globulin | - | - | - | - | [3] 60 60, 65, 284 |
| 13 | Bone marrow transplantation | - | - | - | - | [4] 51 51, 60, 284, 285 |
| 14 | BPX-501 T cells | - | - | - | - | [4] 65 65, 284, 285, 326 |
| 15 | Busulfan | [1] Busulfan Busulfan | [1] D00248
D00248
| - | - | [13] 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
| 16 | Busulfan, Cyclophosphamide, ATG, GCSF | [2] Busulfan Busulfan, Cyclophosphamide | [3] D00248
D00248
,
D00287
,
D07760
| - | - | [2] 65 65, 284 |
| 17 | Busulfan, Fludarabine, ATG, TLI | [2] Busulfan Busulfan, Fludarabine | [3] D00248
D00248
,
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 |
| 18 | Campath, Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] D00287
D00287
,
D01907
,
D07760
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 |
| 19 | CD3/CD19 depleted leukocytes | - | - | - | - | [1] 284 284 |
| 20 | CD34 Stem Cell Selection Therapy | - | - | - | - | [3] 60 60, 65, 284 |
| 21 | CD45RA depleted leukocytes | - | - | - | - | [1] 284 284 |
| 22 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [45] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
| 23 | Cyclophosphamide Dose Level 1 | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [2] 65 65, 284 |
| 24 | Cyclophosphamide Dose Level 2 | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [2] 65 65, 284 |
| 25 | Cyclophosphamide Dose Level 3 | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [2] 65 65, 284 |
| 26 | Cyclophosphamide Dose Level 4 | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [2] 65 65, 284 |
| 27 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 11 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 107, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 |
| 28 | DACLIZUMAB | [1] Daclizumab Daclizumab | [1] D03639
D03639
| [1] IL2RA IL2RA 💬 | [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [8] 13 13, 56, 60, 65, 97, 107, 283, 284 |
| 29 | Deferasirox | [1] Deferasirox Deferasirox | [1] D03669
D03669
| - | - | [3] 254 254, 284, 286 |
| 30 | Deferitazole | [1] Deferitazole Deferitazole | [1] D10388
D10388
| - | - | [1] 284 284 |
| 31 | Deferoxamine | [1] Deferoxamine Deferoxamine | [2] D01186
D01186
,
D03670
| - | - | [2] 284 284, 286 |
| 32 | Desferal | [1] Deferoxamine Deferoxamine | [2] D01186
D01186
,
D03670
| - | - | [2] 284 284, 286 |
| 33 | DFO | - | - | - | - | [3] 46 46, 284, 286 |
| 34 | ELTROMBOPAG | [1] Eltrombopag Eltrombopag | - | - | - | [5] 60 60, 63, 65, 284, 285 |
| 35 | Enriched Hematopoetic Stem Cell Infusion | - | - | - | - | [3] 13 13, 19, 284 |
| 36 | Exjade | [1] Deferasirox Deferasirox | [1] D03669
D03669
| - | - | [3] 254 254, 284, 286 |
| 37 | FBS0701 | - | - | - | - | [1] 284 284 |
| 38 | FBS0701 CAPSULE | - | - | - | - | [1] 284 284 |
| 39 | FBS0701/SSP004184 | - | - | - | - | [1] 284 284 |
| 40 | Filgrastim | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [28] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
| 41 | Fludarabine | [1] Fludarabine Fludarabine | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [18] 13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
| 42 | Fludarabine monophosphate | [1] Fludarabine Fludarabine | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [3] 65 65, 284, 326 |
| 43 | Fludarabine phosphate | [2] Fludarabine Fludarabine, Phosphate ion | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [12] 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
| 44 | G-CSF | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [16] 2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 |
| 45 | Human Placental Derived Stem Cell | - | - | - | - | [4] 19 19, 20, 60, 284 |
| 46 | Hydroxide | [1] Hydroxide ion Hydroxide ion | - | - | - | [5] 11 11, 46, 96, 97, 284 |
| 47 | Hydroxyurea | [1] Hydroxyurea Hydroxyurea | [1] D00341
D00341
| [1] RRM2 RRM2 💬 | [6] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | [8] 3 3, 13, 19, 20, 65, 85, 86, 284 |
| 48 | ICL670 | - | - | - | - | [3] 60 60, 284, 286 |
| 49 | Iron | [1] Iron Iron | - | - | - | [6] 18 18, 96, 97, 238, 254, 284 |
| 50 | IRON CHELATING AGENTS | - | - | - | - | [1] 284 284 |
| 51 | L-leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [1] 284 284 |
| 52 | Lenalidomide | [1] Lenalidomide Lenalidomide | [1] D04687
D04687
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
| 53 | Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [11] 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
| 54 | Leukapheresis | - | - | - | - | [5] 49 49, 51, 96, 284, 285 |
| 55 | Magnesium | [1] Magnesium Magnesium | - | - | - | [19] 3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
| 56 | Magnesium hydroxide | [3] Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | [1] D00731
D00731
| - | - | [1] 284 284 |
| 57 | Melphalan | [1] Melphalan Melphalan | [1] D00369
D00369
| - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
| 58 | Mesenchymal Stromal Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [10] 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
| 59 | Methotrexate | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
| 60 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
| 61 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 62 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| 63 | Myeloablative Preparative Regimen | - | - | - | - | [3] 62 62, 65, 284 |
| 64 | Other: Laboratory Biomarker Analysis | - | - | - | - | [21] 11 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 |
| 65 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 |
| 66 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [33] 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
| 67 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| 68 | Radiation therapy | - | - | - | - | [3] 13 13, 284, 285 |
| 69 | Radiation: radiation therapy | - | - | - | - | [5] 34 34, 60, 65, 284, 285 |
| 70 | Radiation: Total Body Irradiation | - | - | - | - | [7] 36 36, 49, 51, 60, 65, 283, 284 |
| 71 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 |
| 72 | Reduced Intensity Preparative Regimen | - | - | - | - | [3] 62 62, 65, 284 |
| 73 | Reduced Toxicity Ablative Regimen | - | - | - | - | [3] 62 62, 65, 284 |
| 74 | Rimiducid | [1] Rimiducid Rimiducid | [1] D11195
D11195
| [1] CASP9 CASP9 💬 | [35] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [6] 19 19, 60, 65, 284, 285, 326 |
| 75 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
| 76 | Rivogenlecleucel | - | - | - | - | [6] 19 19, 60, 65, 284, 285, 326 |
| 77 | SOTATERCEPT | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [2] 86 86, 284 |
| 78 | Sotatercept with prednisone boost | [2] Prednisone Prednisone, Sotatercept | [2] D00473
D00473
,
D09670
| [2] ACVR2A ACVR2A, NR3C1 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 284 284 |
| 79 | SSP-004184 100 mg | - | - | - | - | [1] 284 284 |
| 80 | SSP-004184 100 mg Capsule | - | - | - | - | [1] 284 284 |
| 81 | SSP-004184 250 mg | - | - | - | - | [1] 284 284 |
| 82 | SSP-004184 250 mg Capsule | - | - | - | - | [1] 284 284 |
| 83 | SSP-004184 375 mg | - | - | - | - | [1] 284 284 |
| 84 | SSP-004184 375 mg Capsule | - | - | - | - | [1] 284 284 |
| 85 | SSP-004184 50 mg | - | - | - | - | [1] 284 284 |
| 86 | SSP-004184 50 mg Capsule | - | - | - | - | [1] 284 284 |
| 87 | SSP-004184 500 mg | - | - | - | - | [1] 284 284 |
| 88 | SSP-004184 500 mg Capsule | - | - | - | - | [1] 284 284 |
| 89 | SSP-004184AQ 100 mg | - | - | - | - | [1] 284 284 |
| 90 | SSP-004184AQ 100 mg Capsule | - | - | - | - | [1] 284 284 |
| 91 | SSP-004184AQ 200 mg | - | - | - | - | [1] 284 284 |
| 92 | SSP-004184AQ 200 mg Capsule | - | - | - | - | [1] 284 284 |
| 93 | SSP-004184AQ 250 mg | - | - | - | - | [1] 284 284 |
| 94 | SSP-004184AQ 250 mg Capsule | - | - | - | - | [1] 284 284 |
| 95 | SSP-004184AQ 375 mg | - | - | - | - | [1] 284 284 |
| 96 | SSP-004184AQ 375 mg Capsule | - | - | - | - | [1] 284 284 |
| 97 | SSP-004184AQ 50 mg | - | - | - | - | [1] 284 284 |
| 98 | SSP-004184AQ 50 mg Capsule | - | - | - | - | [1] 284 284 |
| 99 | Stem Cell Infusion | - | - | - | - | [5] 28 28, 60, 65, 284, 285 |
| 100 | Stem Cell Transplant | - | - | - | - | [6] 19 19, 20, 60, 65, 164, 284 |
| 101 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
| 102 | Thiotepa | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [12] 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
| 103 | Thiotepa--escalated dose | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [4] 19 19, 20, 65, 284 |
| 104 | Thiotepa--single daily dose | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [4] 19 19, 20, 65, 284 |
| 105 | Total lymphoid irradiation | - | - | - | - | [3] 65 65, 284, 326 |
| 106 | Trifluoperazine | [1] Trifluoperazine Trifluoperazine | [3] D00799
D00799
,
D01448
,
D08636
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 283 283, 284 |
| 107 | Umbilical Cord Blood Transplantation | - | - | - | - | [5] 60 60, 65, 284, 285, 326 |